Related Experiment Video
Updated: Apr 12, 2026
10:21
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
10.8K
[Intramyocardial bridges: anatomo-pathological characteristics, diagnosis, and therapeutic strategies]
Giornale Italiano Di Cardiologia (2006)
|May 12, 2015
Insights
Intramyocardial bridges are heart artery segments within the cardiac muscle. While often asymptomatic, they can cause serious cardiac events, necessitating beta-blocker treatment for symptomatic individuals.
Area of Science:
- Cardiology
- Anatomy
- Pathophysiology
Context:
- Intramyocardial bridge (IMB) is an anatomical variant where a segment of a major epicardial coronary artery tunnels within the myocardium.
- This condition is typically asymptomatic but can present with significant clinical manifestations.
Purpose:
- To define intramyocardial bridges and outline their clinical significance.
- To describe the potential complications and current treatment strategies for symptomatic patients.
Summary:
- Intramyocardial bridges involve coronary arteries running through heart muscle, a condition also known as coronary tunneling.
- Although usually benign, IMBs can precipitate acute coronary syndromes, arrhythmias, and sudden cardiac death in some individuals.
- Pharmacological management, primarily with beta-blockers, is the standard treatment for symptomatic patients.
Impact:
- Enhances understanding of a rare coronary artery anomaly.
- Highlights the importance of recognizing IMBs in the differential diagnosis of cardiac events.
- Informs clinical practice regarding the management of symptomatic intramyocardial bridges.
Abstract:
Intramyocardial bridge is defined as the segment of a major epicardial coronary artery that runs within the cardiac muscle wall (coronary tunneling). Usually, this kind of anatomic variant is asymptomatic but sometimes it may lead to acute coronary syndrome and/or arrhythmias, and more rarely to sudden cardiac death. Treatment for symptomatic patients is pharmacological, using beta-blockers.
Related Concept Videos
01:21Myocarditis I: Introduction
612
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
612
01:27Myocarditis II: Clinical Features and Diagnostic Tests
457
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
457
01:30Cardiomyopathy II: Dilated Cardiomyopathy
801
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
801
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
767
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
767
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
485
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
485
01:29Cardiomyopathy V: Interprofessional Care
695
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
695